Literature DB >> 30343520

Reducing DNA damage by formaldehyde in liquid-based cytology preservation solutions to enable the molecular testing of lung cancer specimens.

Yukiko Matsuo1, Tsutomu Yoshida2,3, Kazuya Yamashita3, Yukitoshi Satoh1.   

Abstract

BACKGROUND: Liquid-based cytology (LBC) is a useful cytopathological method, and LBC lung adenocarcinoma specimens may be used for genetic analysis in the near future. In the current study, the authors determined whether LBC specimens can be used for epidermal growth factor receptor (EGFR) mutation analysis in human lung adenocarcinoma cell lines.
METHODS: Genomic DNA was extracted from 3 lung adenocarcinoma cell lines that were fixed in LBC preservation solution using 2 protocols (one for cultured cells and one for tissues) of a DNA extraction kit. Different fixation times were tested for each protocol: 30 minutes, 1 hour, and 1 to 9 days. As controls, cells also were fixed in 10% formalin or 95% ethanol. The authors investigated the effect of fixation time on DNA fragmentation, polymerase chain reaction (PCR) amplification, and EGFR mutation detection.
RESULTS: The DNA yield of LBC specimens tended to decrease depending on fixation time. When using the DNA extraction protocol for tissues, PCR amplification was successful after 9 days of fixation, although extracted genomic DNA that was fixed for >1 hour demonstrated fragmentation. Mutation analyses using the Cycleave PCR method were successful after 7 days of fixation. The DNA extraction protocol for tissues was appropriate for lung adenocarcinoma cell lines that were stored for >1 day in a preservative solution. The results of the current study demonstrated that EGFR mutations can be detected on day 7 using lung adenocarcinoma cell lines fixed in CytoRich Red preservative.
CONCLUSIONS: When LBC specimens are used for targeted molecular genetic testing, the appropriate preservative solution and extraction protocol first should be determined.
© 2018 American Cancer Society.

Entities:  

Keywords:  DNA degradation; epidermal growth factor receptor (EGFR); formaldehyde; liquid-based cytology; lung cancer

Mesh:

Substances:

Year:  2018        PMID: 30343520     DOI: 10.1002/cncy.22069

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  6 in total

1.  Impact of LBC Fixative Type and Fixation Time on Molecular Analysis of Pancreatic Cancer Cells: A Comparative Study of Cell Morphology, Antigenicity and Nucleic Acids.

Authors:  Junya Izuhara; Kazuki Kanayama
Journal:  J Cytol       Date:  2022-05-20       Impact factor: 1.577

2.  Method for preservation of DNA stability of liquid-based cytology specimens from a lung adenocarcinoma cell line.

Authors:  Yukiko Matsuo; Kazuya Yamashita; Tsutomu Yoshida; Yukitoshi Satoh
Journal:  Virchows Arch       Date:  2020-08-31       Impact factor: 4.064

3.  Comprehensive validation of liquid-based cytology specimens for next-generation sequencing in cancer genome analysis.

Authors:  Toshiaki Akahane; Tomomi Yamaguchi; Yasutaka Kato; Seiya Yokoyama; Taiji Hamada; Yukari Nishida; Michiyo Higashi; Hiroshi Nishihara; Shinsuke Suzuki; Shinichi Ueno; Akihide Tanimoto
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

4.  Molecular Analysis of Liquid-Based Cytological Specimen Using Virtually Positive Sputum with Adenocarcinoma Cells.

Authors:  Takeshi Nishikawa; Tomomi Fujii; Shigenobu Tatsumi; Aya Sugimoto; Yoko Sekita-Hatakeyama; Keiji Shimada; Masaharu Yamazaki; Kinta Hatakeyama; Chiho Ohbayashi
Journal:  Diagnostics (Basel)       Date:  2020-02-05

Review 5.  Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review.

Authors:  Alessandro Caputo; Angela D'Ardia; Francesco Sabbatino; Caterina Picariello; Chiara Ciaparrone; Pio Zeppa; Antonio D'Antonio
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

6.  A Comparative Study of Liquid-Based Cytology and DNA Image Cytometry in the Diagnosis of Serous Effusion.

Authors:  Shaohua Wang; Dan Li; Jieqiong Wang; Yu Wan; Conggai Huang; Bo Yang; Xiaoqin Tang; Gang Tian; Zhihui Yang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.